BTG International Germany GmbH

Company

    • Company type:
      • Manufacturer
      • Research & Development
    • Year founded:
    • 2000
    • Employees (at the site):
    • 45
    • Turnover range:
    • <5m EUR
    • Products/services:
    • Oncology; Research, Production and Distribution of Drugs; Tissue Engineering; Gene Transfer and Gene Therapy; Diabetics; Endocrinology; Biomaterials; Implants; Neurology; Substitution of Organs/Artificial Organs

    • Core competencies:
    • Biological Drug Delivery, Long term delivery of therapeutic Proteins using encapsulated cell systems, GMP Production of Biopolymers

    • Language skills:
    • English
    • Key Tech / section:
      • Biotechnology: Drug delivery
      • Biotechnology: Therapeutic drug development
      • Biotechnology: Tissue engineering and regenerative medicine
      • Medical Technology: Implants, biomaterials, tissue engineering
      • Medical Technology: Neurology
    • Industries NACE:
      • 71: Architectural and engineering activities; technical testing and analysis
      • 71.1: Architectural and engineering activities and related technical consultancy
      • 21: Manufacture of basic pharmaceutical products and pharmaceutical preparations
    • Certification:
    • DIN ISO 9000, GMP, GLP, Drug Manufacturing License

    • Sales markets - target industries:
    • not available
    • Sales markets - target countries:
    • not available
    • Cooperation offers:
    • not available
    • Contact person:
    • Peter Geigle (Mr.)
      - Management